Court of Justice 25 March 2021, Case C-591/16 P: Judgment of the Court (Fourth Chamber) of 25 March 2021 — H. Lundbeck A/S, Lundbeck Ltd v European Commission, European Federation of Pharmaceutical Industries and Associations (EFPIA) (Appeal — Competition — Agreements, decisions and concerted practices — Pharmaceutical products — Market for antidepressants (citalopram) — Settlement agreements relating to disputes concerning process patents concluded by a manufacturer of originator medicines who is the holder of those patents and manufacturers of generic medicines — Article 101 TFEU — Potential competition — Restriction by object — Characterisation — Calculation of the amount of the fine — Sales directly or indirectly related to the infringement)

Also known as

European Union · · · 25-03-2021

31.5.2021 EN Official Journal of the European Union C 206/3 Judgment of the Court (Fourth Chamber) of 25 March 2021 — H. Lundbeck A/S, Lundbeck Ltd v European Commission, European Federation of Pharmaceutical Industries and Associations (EFPIA) (Case C-591/16 P) (1) (Appeal - Competition - Agreements, decisions and concerted practices - Pharmaceutical products - Market for antidepressants

Read the full text

This document is published by eur-lex.europa.eu.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.